2-(4-Methoxymethyl-piperidin-1-yl)-ethylamine, 500mg

Ethyl 3-Bromo-2-(bromomethyl)propionate>97.0%(GC)25g

4-(Vinylsulfonamido)benzoic acid, 98%, 250mg

3-(4-Nitrophenoxy)benzaldehyde, 97.0%, 1g

2-(1-Hydroxyethyl)pyrimidin-5-ol, 95+%, 500mg

N'-(4-methoxy-7-methyl-1,3-benzothiazol-2-yl)-N,N-dimethylpropane-1,3-diamine, 95.0%, 500mg

Piperazine Citrate>98.0%(T)25g

4-(Trifluoromethyl)phenylurethane, 95.0%, 5g

4-BROMOISOQUINOLIN-8-OL, 95.0%, 50mg

(4-Fluoro-3,5-dimethoxyphenyl)boronic acid, 95.0%, 250mg

Microliter syringe GASTIGHT® series 1700 Point type 2, 10 µl, 1701 RN, 1 piece

Chloranil>98.0%(GC)(T)25g

2,2'-((4-((2-Hydroxyethyl)amino)-3-nitrophenyl)azanediyl)diethanol, 95.0%, 1g